The current R&D outsourcing market is growing annually at ∼15%, with a predicted market of US$36 billion by 2010. However, top tier contract research organizations (CROs) are attempting to transform their profitability by focusing on higher value-added services, such as preclinical and bioanalytical testing, leading to a shortage of high-quality formulation CROsPeer reviewe
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
SummaryTransitional medicine/science is shifting the medical research paradigm from compound-based t...
Trabajo presentado al DRUID Society Conference on Innovation and Competitiveness - Dynamics of Organ...
The pharmacoeconomic realities of drug discovery are that biopharmaceutical firms need to discover a...
Purpose of the paper: In recent years, the Pharma Industry (PI) has undergone radical changes in R&a...
With the ever increasing Research and Development cost for the pharmaceutical industries, the cost o...
Purpose of the paper: In recent years, the Pharma Industry (PI) has undergone radical changes in R&a...
Aim of the Paper The aim of our study is to better understand the role of Contract Research Organiz...
Pharmaceutical, biotechnology and medical device companies hire contract research organizations (CRO...
Purpose: The aging of the population, high prevalence of chronic diseases, and increased need for ev...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characteris...
The market is growing for clinical research organizations (CROs) like Gail Baillargeon\u27s Bangor-b...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
Bioanalysis is a specific discipline within analytical chemistry involved in the quantitative measur...
The pharmaceutical industry has responded to the declining research and development (R&D) productivi...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
SummaryTransitional medicine/science is shifting the medical research paradigm from compound-based t...
Trabajo presentado al DRUID Society Conference on Innovation and Competitiveness - Dynamics of Organ...
The pharmacoeconomic realities of drug discovery are that biopharmaceutical firms need to discover a...
Purpose of the paper: In recent years, the Pharma Industry (PI) has undergone radical changes in R&a...
With the ever increasing Research and Development cost for the pharmaceutical industries, the cost o...
Purpose of the paper: In recent years, the Pharma Industry (PI) has undergone radical changes in R&a...
Aim of the Paper The aim of our study is to better understand the role of Contract Research Organiz...
Pharmaceutical, biotechnology and medical device companies hire contract research organizations (CRO...
Purpose: The aging of the population, high prevalence of chronic diseases, and increased need for ev...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characteris...
The market is growing for clinical research organizations (CROs) like Gail Baillargeon\u27s Bangor-b...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
Bioanalysis is a specific discipline within analytical chemistry involved in the quantitative measur...
The pharmaceutical industry has responded to the declining research and development (R&D) productivi...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
SummaryTransitional medicine/science is shifting the medical research paradigm from compound-based t...
Trabajo presentado al DRUID Society Conference on Innovation and Competitiveness - Dynamics of Organ...
DOI
Add to ORKG